Encompass Health Co. (NYSE:EHC) Shares Sold by Crossmark Global Holdings Inc.

Crossmark Global Holdings Inc. lessened its position in Encompass Health Co. (NYSE:EHCGet Rating) by 92.0% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 9,450 shares of the company’s stock after selling 109,165 shares during the period. Crossmark Global Holdings Inc.’s holdings in Encompass Health were worth $427,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the company. Baupost Group LLC MA raised its position in shares of Encompass Health by 318.9% in the first quarter. Baupost Group LLC MA now owns 3,000,000 shares of the company’s stock valued at $213,330,000 after buying an additional 2,283,900 shares during the last quarter. State Street Corp increased its position in Encompass Health by 5.0% during the first quarter. State Street Corp now owns 2,733,254 shares of the company’s stock worth $195,118,000 after purchasing an additional 130,504 shares during the last quarter. Victory Capital Management Inc. increased its position in Encompass Health by 40.0% during the second quarter. Victory Capital Management Inc. now owns 2,146,910 shares of the company’s stock worth $120,335,000 after purchasing an additional 613,547 shares during the last quarter. Massachusetts Financial Services Co. MA increased its position in Encompass Health by 88.8% during the second quarter. Massachusetts Financial Services Co. MA now owns 1,685,880 shares of the company’s stock worth $94,494,000 after purchasing an additional 792,813 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its position in Encompass Health by 21.0% during the first quarter. Dimensional Fund Advisors LP now owns 1,464,313 shares of the company’s stock worth $104,127,000 after purchasing an additional 254,385 shares during the last quarter. Institutional investors and hedge funds own 96.14% of the company’s stock.

Insider Activity

In other news, Director Greg D. Carmichael bought 1,830 shares of the firm’s stock in a transaction dated Monday, October 31st. The stock was acquired at an average cost of $54.67 per share, for a total transaction of $100,046.10. Following the completion of the purchase, the director now owns 10,546 shares of the company’s stock, valued at $576,549.82. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Insiders own 2.70% of the company’s stock.

Encompass Health Price Performance

EHC opened at $62.68 on Monday. The company has a quick ratio of 1.21, a current ratio of 1.21 and a debt-to-equity ratio of 1.59. Encompass Health Co. has a 52-week low of $44.33 and a 52-week high of $74.61. The company has a 50 day moving average of $58.43 and a two-hundred day moving average of $53.25. The company has a market cap of $6.25 billion, a P/E ratio of 23.04, a P/E/G ratio of 2.64 and a beta of 1.03.

Encompass Health (NYSE:EHCGet Rating) last announced its earnings results on Wednesday, October 26th. The company reported $0.67 earnings per share for the quarter, missing the consensus estimate of $0.68 by ($0.01). The firm had revenue of $1.09 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Encompass Health had a net margin of 5.39% and a return on equity of 15.59%. On average, analysts expect that Encompass Health Co. will post 2.79 earnings per share for the current year.

Analyst Upgrades and Downgrades

Several brokerages recently commented on EHC. Raymond James upped their price target on shares of Encompass Health from $65.00 to $72.00 and gave the stock a “strong-buy” rating in a research report on Friday, October 28th. Stephens dropped their price target on shares of Encompass Health from $60.00 to $58.00 and set an “overweight” rating for the company in a research report on Friday, October 28th. TheStreet raised shares of Encompass Health from a “c+” rating to a “b-” rating in a research report on Wednesday, December 21st. Finally, StockNews.com initiated coverage on shares of Encompass Health in a research note on Wednesday, October 12th. They set a “hold” rating for the company. One analyst has rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $64.13.

Encompass Health Company Profile

(Get Rating)

Encompass Health Corp. engages in the provision of post-acute healthcare services. It operates through the Inpatient Rehabilitation and Home Health and Hospice segments. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provide rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions and amputations.

Featured Articles

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Co. (NYSE:EHCGet Rating).

Institutional Ownership by Quarter for Encompass Health (NYSE:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.